🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Purpose of this trial is: * to determine complete response rate (CRR) ...
Status
Completed
Location
1st Dept. of Medicine, Cologne University Hospital
Start Date
2012-10
Trial ID
NCT01569204
A Randomized Phase IIb Study, Evaluating Efficacy of Salvage Therapy with B...
Status
Recruiting
Location
Institut Català D'Oncologia - Hospital Germans Trias I Pujol
Start Date
2020-06-01
Trial ID
NCT04378647
This study will test brentuximab vedotin to see if it is safe for people wi...
Status
Withdrawn
Location
University of California at San Francisco
Start Date
2022-12-31
Trial ID
NCT05244473
Treatments Being Tested
The purpose of this study is to learn the effects of brentuximab vedotin (S...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2011-05
Trial ID
NCT01396070
Treatments Being Tested
The purpose of this study is to evaluate pembrolizumab (MK-3475) in the tre...
Status
Completed
Location
Multiple Locations
Start Date
2016-05-23
Trial ID
NCT02684292
Treatments Being Tested
The purpose of this study is to evaluate how safe and effective the combina...
Status
Terminated
Location
Northwestern University
Start Date
2013-03-05
Trial ID
NCT01805037
Treatments Being Tested
This pilot phase I/II trial studies the side effects and the best dose of b...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2013-03-08
Trial ID
NCT01771107
Treatments Being Tested
Generally, pediatric patients tolerate acute toxicities but are vulnerable ...
Status
Recruiting
Location
Shanghai Children's Medical Center
Start Date
2024-09-25
Trial ID
NCT06563245
The goal of this observational study is to evaluate how well brentuximab ve...
Status
Recruiting
Location
Hospital Universitario A Coruña
Start Date
2026-02-15
Trial ID
NCT07624838
Treatments Being Tested
This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Status
Completed
Location
CH Victor Dupouy
Start Date
2015-04
Trial ID
NCT02298283